Rituxan
NDC 50242-051, rituximab, injection, solution, from Genentech, Inc..
- Product NDC
- 50242-051
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103705
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RITUXIMAB10 mg/mL
Pharmacologic classes
CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-051-21 | 50242005121 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-051-21) / 10 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b172773b-3905-4a1c-ad95-bab4b6126563Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-051
Use it
Look up 50242-051 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.